Osteonecrosis of the Jaw in a Patient on Denosumab

被引：187

作者：

Aghaloo, Tara L. ^{[1
]}

Felsenfeld, Alan L. ^{[1
]}

Tetradis, Sotirios ^{[1
]}

机构：

[1] Univ Calif Los Angeles, Sch Dent, Sect Oral & Maxillofacial Surg, Los Angeles, CA 90095 USA

来源：

JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY | 2010年 / 68卷 / 05期

关键词：

BISPHOSPHONATE-RELATED OSTEONECROSIS; GIANT-CELL TUMOR; FACTOR-KAPPA-B; RISK-FACTORS; POSTMENOPAUSAL WOMEN; BONE METASTASES; BREAST-CANCER; RECEPTOR ACTIVATOR; MULTIPLE-MYELOMA; AVASCULAR NECROSIS;

D O I：

10.1016/j.joms.2009.10.010

中图分类号：

R78 [口腔科学];

学科分类号：

1003 ;

摘要：

[No abstract available]

引用

页码：959 / 963

页数：5

共 65 条

[1] The Pathogenesis of Bisphosphonate-Related Osteonecrosis of the Jaw: So Many Hypotheses, So Few Data [J].

Allen, Matthew R. ;

Burr, David B. .

JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2009, 67 (05) :61-70

[2] Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases [J].

Bagan, JV ;

Murillo, J ;

Jimenez, Y ;

Poveda, R ;

Milian, MA ;

Sanchis, JM ;

Silvestre, FJ ;

Scully, C .

JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2005, 34 (02) :120-123

[3] Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors [J].

Bamias, A ;

Kastritis, E ;

Bamia, C ;

Moulopoulos, LA ;

Melakopoulos, L ;

Bozas, G ;

Koutsoukou, V ;

Gika, D ;

Anagnostopoulos, A ;

Papadimitriou, C ;

Terpos, E ;

Dimopoulos, MA .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8580-8587

[4] RANKL, RANK, osteoprotegerin:: key partners of osteoimmunology and vascular diseases [J].

Baud'huin, M. ;

Lamoureuxa, F. ;

Duplomba, L. ;

Redini, F. ;

Heymann, D. .

CELLULAR AND MOLECULAR LIFE SCIENCES, 2007, 64 (18) :2334-2350

[5] A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women [J].

Bekker, PJ ;

Holloway, DL ;

Rasmussen, AS ;

Murphy, R ;

Martin, SW ;

Leese, PT ;

Holmes, GB ;

Dunstan, CR ;

DePaoli, AM .

JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (07) :1059-1066

[6] A study of the biological receptor activator of nuclear factor-κB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer [J].

Body, JJ ;

Facon, T ;

Coleman, RE ;

Lipton, A ;

Geurs, F ;

Fan, M ;

Holloway, D ;

Peterson, MC ;

Bekker, P .

CLINICAL CANCER RESEARCH, 2006, 12 (04) :1221-1228

[7] Ten years' experience with alendronate for osteoporosis in postmenopausal women [J].

Bone, HG ;

Hosking, D ;

Devogelaer, J ;

Tucci, JR ;

Emkey, RD ;

Tonino, RP ;

Rodriguez-Portales, JA ;

Downs, RW ;

Gupta, J ;

Santora, AC ;

Liberman, UA .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (12) :1189-1199

[8] Osteoclast differentiation and activation [J].

Boyle, WJ ;

Simonet, WS ;

Lacey, DL .

NATURE, 2003, 423 (6937) :337-342

[9]

Brown JP, 2009, J BONE MINER RES, V24, P153, DOI [10.1359/jbmr.080901, 10.1359/JBMR.0809010]

[10] Bisphosphonates and jaw osteonecrosis: The UAMS experience [J].

Clarke, Brett M. ;

Boyette, Jennings ;

Vural, Emre ;

Suen, James Y. ;

Anaissie, Elias J. ;

Stack, Brendan C., Jr. .

OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2007, 136 (03) :396-400

← 1 2 3 4 5 6 7 →